Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fraser McBlane
Observed names:
F. McBlane,
McBlane, F
Institution:
Novartis (Switzerland)
Observed institutions:
University of Copenhagen,
Novartis (Switzerland),
University of Basel,
IFOM,
Joint Research Centre,
Institute of Biomedical Technologies,
National Research Council,
Novartis Institutes for BioMedical Research,
European Institute of Oncology,
University of Edinburgh
show all 10
OpenAlex ID:
A5090670617
ATAD2 Is a Novel Cofactor for MYC, Overexpressed and Amplified in Aggressive Tumors
2009
·
Marco Ciró
, Elena Prosperini
, et al.
·
Cancer Research
·
246
PDF
DNA Double-Strand Breaks in Immunoglobulin Genes Undergoing Somatic Hypermutation
2000
·
Linda Bross
, Yosho Fukita
, et al.
·
Immunity
·
193
PDF
Immunogenicity assessment of AAV-based gene therapies: An IQ consortium industry white paper
2022
·
Tong-yuan Yang
, Manuela Braun
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
130
PDF
Stimulation of V(D)J recombination by histone acetylation
2000
·
Fraser McBlane
, Joan Boyes
·
Current Biology
·
124
PDF
Recombinase, chromosomal translocations and lymphoid neoplasia: Targeting mistakes and repair failures
2006
·
Rodrig Marculescu
, Katrina Vanura
, et al.
·
DNA repair
·
113
Molecular Signatures of Self-Renewal, Differentiation, and Lineage Choice in Multipotential Hemopoietic Progenitor Cells In Vitro
2003
·
Ludovica Bruno
, Reinhard Hoffmann
, et al.
·
Molecular and Cellular Biology
·
97
RSSsite: a reference database and prediction tool for the identification of cryptic Recombination Signal Sequences in human and murine genomes
2010
·
I. Merelli
, A. Guffanti
, et al.
·
Nucleic Acids Research
·
90
PDF
Regulation of V(D)J recombination by nucleosome positioning at recombination signal sequences
2003
·
Matthias Baumann
, Adamantios Mamais
, et al.
·
The EMBO Journal
·
86
A systematic review of immunosuppressive protocols used in AAV gene therapy for monogenic disorders
2024
·
Besarte Vrellaku
, Ilda Sethw Hassan
, et al.
·
Molecular Therapy
·
80
PDF
The PHD Domain of Np95 (mUHRF1) Is Involved in Large-Scale Reorganization of Pericentromeric Heterochromatin
2008
·
Roberto Papait
, Christian Pistore
, et al.
·
Molecular Biology of the Cell
·
75
The RING Domain of RAG1 Ubiquitylates Histone H3: A Novel Activity in Chromatin-Mediated Regulation of V(D)J Joining
2010
·
Ursula Grazini
, Federica Zanardi
, et al.
·
Molecular Cell
·
62
PDF
Preexisting antibody assays for gene therapy: Considerations on patient selection cutoffs and companion diagnostic requirements
2024
·
Manuela Braun
, Claudia Lange
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
30
Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma
2021
·
Karen Thudium Mueller
, Stephan A. Grupp
, et al.
·
Blood Advances
·
30
A cell-based immunogenicity assay to detect antibodies against chimeric antigen receptor expressed by tisagenlecleucel
2019
·
Bernd Potthoff
, Fraser McBlane
, et al.
·
Journal of Immunological Methods
·
28
PDF
PK/PD and Bioanalytical Considerations of AAV-Based Gene Therapies: an IQ Consortium Industry Position Paper
2023
·
Uma Kavita
, Kefeng Sun
, et al.
·
The AAPS Journal
·
22
V(D)J Recombinase-Mediated Processing of Coding Junctions at Cryptic Recombination Signal Sequences in Peripheral T Cells during Human Development
2006
·
Janet M Murray
, J Patrick O’Neill
, et al.
·
The Journal of Immunology
·
18
PDF
Impact of pre-existing immunity on safety and biodistribution of a single AAV9 vector intrathecal injection in cynomolgus monkeys
2025
·
Maria Vono
, Tony del Rio
, et al.
·
Molecular Therapy — Methods & Clinical Development
·
11
Abstract 509: Conversion of cellular kinetic data for chimeric antigen receptor T-cell therapy (CAR-T) into interpretable units
2021
·
Anwesha Chaudhury
, Andrew Stein
, et al.
·
Cancer Research
·
4
Ocular biomarker profiling after complement factor I gene therapy in geographic atrophy secondary to age-related macular degeneration
2024
·
Thomas M Hallam
, Emanuela Gardenal
, et al.
·
medRxiv
·
2
Further characterisation of processes removing EMS premutational lesions in yeast (S. cerevisiae)
1985
·
Fraser McBlane
, Brian Kilbey
·
Mutation Research Letters
·
2
Ocular biomarker profiling after complement factor I gene therapy in geographic atrophy secondary to age-related macular degeneration
2025
·
Thomas M Hallam
, Emanuela Gardenal
, et al.
·
eLife
·
1
Ocular biomarker profiling after complement factor I gene therapy in geographic atrophy secondary to age-related macular degeneration
2024
·
Thomas M Hallam
, Emanuela Gardenal
, et al.
·
eLife
·
1
AAV serotype IVDs for patient selection in gene therapy development: Technical and regulatory considerations by ARDAT consortium
2026
·
Manuela Braun
, Christel Ravesteijn-Verrijt
, et al.
·
Molecular Therapy Advances
Impact of pre-existing immunity on safety and biodistribution of a single AAV9 vector intrathecal injection in cynomolgus monkeys
2026
·
Maria Vono
, Tony del Rio
, et al.
·
Molecular Therapy Advances
Author response: Ocular biomarker profiling after complement factor I gene therapy in geographic atrophy secondary to age-related macular degeneration
2025
·
Thomas M Hallam
, Emanuela Gardenal
, et al.
·
eLife
Show more works
View as search
Works count:
31
Citation count:
1,445
H-index:
16
I10-index:
17
Year
Topic
Type